37131-91-2 Usage
Uses
Used in Pharmaceutical Synthesis:
6-Chloro-4-pyrimidinecarboxylic acid is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its reactivity enables the formation of complex molecules with potential therapeutic applications, contributing to the development of new drugs.
Used in Agrochemical Production:
In the agrochemical industry, 6-Chloro-4-pyrimidinecarboxylic acid serves as a crucial building block for the creation of compounds with pesticidal properties. Its incorporation into these products enhances their effectiveness in controlling pests and diseases in agriculture.
Used in Antiviral and Antimicrobial Drug Development:
6-Chloro-4-pyrimidinecarboxylic acid has been studied for its potential antiviral and antimicrobial properties. Its ability to inhibit the growth of viruses and bacteria makes it a valuable compound in the discovery and development of new antiviral and antimicrobial drugs, addressing the need for novel treatments in the face of emerging resistant strains and viral diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 37131-91-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,1,3 and 1 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 37131-91:
(7*3)+(6*7)+(5*1)+(4*3)+(3*1)+(2*9)+(1*1)=102
102 % 10 = 2
So 37131-91-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H3ClN2O2/c6-4-1-3(5(9)10)7-2-8-4/h1-2H,(H,9,10)
37131-91-2Relevant academic research and scientific papers
COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
-
Page/Page column 91-92, (2010/04/03)
Compounds of formula (I): wherein R1, L2, R2, L3, R3, L4 and R4 are as defined herein, upregulate endogenous utrophin in predictive screens, and thus, are useful for the treatment or prophylaxis of conditions such as Duchenne muscular dystrophy, Becker muscular dystrophy, and cachexia.
BENZAMIDE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS
-
, (2008/06/13)
The invention concerns amide derivatives of formula (I) wherein R 3 is (1-6C)alkyl or halogeno; m is 0-3, p is 0-2 and q is 0-4; each of R 1 and R 2 is a group such as hydroxy, halogeno, trifluoromethyl and cyano; R 4 is a basic group such as amino, (1-6C)alkylamino, di-[(1-6C)alkyl]amino, di-[(1-6C)alkyl]amino-(1-6C)alkyl, di-[(1-6C)alkyl]amino-(2-6C)alkoxy, heteroaryl, heteroaryloxy, heteroaryl-(1-6C)alkoxy, heterocyclyl, heterocyclyloxy and heterocyclyl-(1-6C)alkoxy; and Q 2 is a group such as heteroaryl, heteroaryloxy or heteroaryl-(1-6C)alkoxy which is optionally substituted; or pharmaceutically-acceptable salts or in-vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
